Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

NCT: NCT03706833 · ACTIVE_NOT_RECRUITING

NCT IDNCT03706833
StatusACTIVE_NOT_RECRUITING
Start Date2018-11-30
Completion2031-06-30
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑